TW200738675A - New compounds - Google Patents

New compounds

Info

Publication number
TW200738675A
TW200738675A TW095121779A TW95121779A TW200738675A TW 200738675 A TW200738675 A TW 200738675A TW 095121779 A TW095121779 A TW 095121779A TW 95121779 A TW95121779 A TW 95121779A TW 200738675 A TW200738675 A TW 200738675A
Authority
TW
Taiwan
Prior art keywords
thrombin
conditions
new compounds
inhibition
useful
Prior art date
Application number
TW095121779A
Other languages
English (en)
Inventor
Magnus Polla
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of TW200738675A publication Critical patent/TW200738675A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW095121779A 2005-06-17 2006-06-16 New compounds TW200738675A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0501413 2005-06-17

Publications (1)

Publication Number Publication Date
TW200738675A true TW200738675A (en) 2007-10-16

Family

ID=37532584

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095121779A TW200738675A (en) 2005-06-17 2006-06-16 New compounds

Country Status (18)

Country Link
US (1) US20080207695A1 (zh)
EP (1) EP1893601A1 (zh)
JP (1) JP2008546684A (zh)
KR (1) KR20080021145A (zh)
CN (1) CN101243069A (zh)
AR (1) AR054512A1 (zh)
AU (1) AU2006258300A1 (zh)
BR (1) BRPI0612045A2 (zh)
CA (1) CA2610428A1 (zh)
EC (1) ECSP088111A (zh)
IL (1) IL187580A0 (zh)
MX (1) MX2007016090A (zh)
NO (1) NO20076071L (zh)
RU (1) RU2007146731A (zh)
TW (1) TW200738675A (zh)
UY (1) UY29600A1 (zh)
WO (1) WO2006135323A1 (zh)
ZA (1) ZA200710564B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8354444B2 (en) 2008-09-18 2013-01-15 Hoffmann-La Roche Inc. Substituted pyrrolidine-2-carboxamides
CN113698386B (zh) * 2020-05-22 2022-12-27 上海美悦生物科技发展有限公司 一种4(1h)-吡啶酮类化合物、其药物组合物和用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0820453A4 (en) * 1995-04-04 2001-08-29 Merck & Co Inc THROMBIN INHIBITORS
WO1997001338A1 (en) * 1995-06-27 1997-01-16 Merck & Co., Inc. Pyridinone-thrombin inhibitors
PL329441A1 (en) * 1996-04-23 1999-03-29 Merck & Co Inc Pyrasinone-type thrombin inhibitors
US5668289A (en) * 1996-06-24 1997-09-16 Merck & Co., Inc. Pyridinone thrombin inhibitors
US5792779A (en) * 1997-02-19 1998-08-11 Merck & Co., Inc. Pyridinone thrombin inhibitors
US5866573A (en) * 1997-04-21 1999-02-02 Merck & Co., Inc. Pyrazinone thrombin inhibitors
UA75093C2 (en) * 2000-10-06 2006-03-15 Dimensional Pharm Inc Aminopyridinyl-,aminoguanidinyl-, and alkoxyguanidinesubstituted phenylsubstituted phenylacetamides as protease inhibitors
AU2002246675A1 (en) * 2000-12-18 2002-07-30 Merck And Co., Inc. Thrombin inhibitors
US6946283B2 (en) * 2001-01-05 2005-09-20 William Marsh Rice University Ginkgo biloba levopimaradiene synthase
JP2004520399A (ja) * 2001-02-09 2004-07-08 メルク　エンド　カムパニー　インコーポレーテッド トロンビン阻害剤
SI21097A (sl) * 2001-12-04 2003-06-30 Univerza V Ljubljani Inhibitorji trombina
AR047521A1 (es) * 2004-02-06 2006-01-25 Astrazeneca Ab Compuestos piridin-2-ona utiles como inhibidores de trombina

Also Published As

Publication number Publication date
ECSP088111A (es) 2008-02-20
EP1893601A1 (en) 2008-03-05
IL187580A0 (en) 2008-03-20
WO2006135323A1 (en) 2006-12-21
RU2007146731A (ru) 2009-07-27
UY29600A1 (es) 2007-01-31
AR054512A1 (es) 2007-06-27
CA2610428A1 (en) 2006-12-21
KR20080021145A (ko) 2008-03-06
AU2006258300A1 (en) 2006-12-21
BRPI0612045A2 (pt) 2018-07-24
MX2007016090A (es) 2008-03-10
CN101243069A (zh) 2008-08-13
ZA200710564B (en) 2008-11-26
JP2008546684A (ja) 2008-12-25
NO20076071L (no) 2008-01-08
US20080207695A1 (en) 2008-08-28

Similar Documents

Publication Publication Date Title
UA84460C2 (ru) Применение сульфонилкарбамидов для борьбы с нежелательным ростом растений в культурах бобовых
AU2005273867A1 (en) Benzothienopyridines for use as inhibitors of Eg5 kinesin
MX2009006864A (es) Inhibidores novedosos de c jun-n-terminal cinasas.
TN2012000063A1 (en) Quinazolines as potassium ion channel inhibitors
WO2006023515A3 (en) Novel thiazole inhibitors of fructose 1,6-bisphosphatase
TW200732336A (en) Alyphactic heterocyclic compounds
TW200626610A (en) Analogs of 17-hydroxywortmannin as PI3K inhibitors
GEP20104941B (en) Pyrrolopyridine-based inhibitors of dipeptidyl peptidase iv and methods
IL179728A0 (en) Indoles useful in the treatment of inflammation
NZ608442A (en) Crystalline forms of a factor xa inhibitor
MX2008010801A (es) Indolopiridinas como moduladores de quinesina eg5.
PH12013502359A1 (en) Carboxamide compounds and their use as calpain inhibitors
EP2336138A3 (en) Prodrugs of HIV protease inhibitors
SE0301232D0 (sv) Novel use
GEP20146063B (en) Solid pharmaceutical composition
PL1831209T3 (pl) Inhibitory fosfataz cdc25
TW200732320A (en) Pyrazoles useful in the treatment of inflammation
TW200716571A (en) Heterocyclic reverse transcriptase inhibitors
TNSN06260A1 (en) Process for the preparation of tryptase inhibitors
MX2008001428A (es) Compuestos de imidazolil-pirimidina para uso en el tratamiento de trastornos proliferativos.
ECSP056106A (es) Compuestos novedosos de acido fosfonico como inhibidores de las serina proteasas
WO2008015139A3 (en) Inhibitors of zinc proteases thioaryl substituted and their use
TW200738675A (en) New compounds
TW200600084A (en) Anti-coronavirus compounds
UY28739A1 (es) Nuevos compuestos de piridin-2-ona útiles como inhibidores de trombina